vs
Side-by-side financial comparison of BGSF, INC. (BGSF) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
BGSF, INC. is the larger business by last-quarter revenue ($22.0M vs $18.3M, roughly 1.2× ROCKWELL MEDICAL, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -5.3%, a 2.2% gap on every dollar of revenue. On growth, BGSF, INC. posted the faster year-over-year revenue change (-9.4% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $1.7M). Over the past eight quarters, BGSF, INC.'s revenue compounded faster (-5.3% CAGR vs -10.1%).
BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
BGSF vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.0M | $18.3M |
| Net Profit | $-1.2M | $-554.0K |
| Gross Margin | 35.0% | 21.1% |
| Operating Margin | -17.6% | -2.2% |
| Net Margin | -5.3% | -3.0% |
| Revenue YoY | -9.4% | -25.6% |
| Net Profit YoY | -18.2% | 26.7% |
| EPS (diluted) | $-0.12 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.0M | $18.3M | ||
| Q3 25 | $26.9M | $15.9M | ||
| Q2 25 | $23.5M | $16.1M | ||
| Q1 25 | $20.9M | $18.9M | ||
| Q4 24 | $24.3M | $24.7M | ||
| Q3 24 | $29.8M | $28.3M | ||
| Q2 24 | $25.7M | $25.8M | ||
| Q1 24 | $24.5M | $22.7M |
| Q4 25 | $-1.2M | $-554.0K | ||
| Q3 25 | $-5.8M | $-1.8M | ||
| Q2 25 | $-3.7M | $-1.5M | ||
| Q1 25 | $-722.0K | $-1.5M | ||
| Q4 24 | $-981.0K | $-756.0K | ||
| Q3 24 | $-804.0K | $1.7M | ||
| Q2 24 | $-761.0K | $343.0K | ||
| Q1 24 | $-792.0K | $-1.7M |
| Q4 25 | 35.0% | 21.1% | ||
| Q3 25 | 35.9% | 14.3% | ||
| Q2 25 | 35.8% | 15.6% | ||
| Q1 25 | 36.2% | 16.1% | ||
| Q4 24 | 35.9% | 14.7% | ||
| Q3 24 | 35.9% | 22.0% | ||
| Q2 24 | 37.3% | 17.6% | ||
| Q1 24 | 38.1% | 13.5% |
| Q4 25 | -17.6% | -2.2% | ||
| Q3 25 | -3.5% | -9.9% | ||
| Q2 25 | -18.8% | -8.4% | ||
| Q1 25 | 1.6% | -7.2% | ||
| Q4 24 | -15.7% | -2.1% | ||
| Q3 24 | -3.4% | 6.8% | ||
| Q2 24 | -5.7% | 2.0% | ||
| Q1 24 | 1.7% | -5.8% |
| Q4 25 | -5.3% | -3.0% | ||
| Q3 25 | -21.6% | -11.0% | ||
| Q2 25 | -15.9% | -9.3% | ||
| Q1 25 | -3.5% | -8.0% | ||
| Q4 24 | -4.0% | -3.1% | ||
| Q3 24 | -2.7% | 5.9% | ||
| Q2 24 | -3.0% | 1.3% | ||
| Q1 24 | -3.2% | -7.6% |
| Q4 25 | $-0.12 | $-0.01 | ||
| Q3 25 | $-0.52 | $-0.05 | ||
| Q2 25 | $-0.34 | $-0.05 | ||
| Q1 25 | $-0.06 | $-0.04 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | $-0.07 | $0.04 | ||
| Q2 24 | $-0.07 | $0.01 | ||
| Q1 24 | — | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $48.1M | $37.0M |
| Total Assets | $57.8M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.7M | ||
| Q3 25 | $41.2M | $13.6M | ||
| Q2 25 | $2.8M | $12.5M | ||
| Q1 25 | $2.0M | $11.4M | ||
| Q4 24 | $32.0K | $15.7M | ||
| Q3 24 | $262 | $12.3M | ||
| Q2 24 | $226 | $11.9M | ||
| Q1 24 | $50 | $6.6M |
| Q4 25 | $48.1M | $37.0M | ||
| Q3 25 | $50.7M | $37.0M | ||
| Q2 25 | $78.3M | $30.4M | ||
| Q1 25 | $81.8M | $31.5M | ||
| Q4 24 | $82.3M | $32.6M | ||
| Q3 24 | $82.9M | $29.1M | ||
| Q2 24 | $83.2M | $23.5M | ||
| Q1 24 | $83.6M | $20.6M |
| Q4 25 | $57.8M | $57.1M | ||
| Q3 25 | $83.6M | $57.5M | ||
| Q2 25 | $149.7M | $52.6M | ||
| Q1 25 | $152.3M | $54.0M | ||
| Q4 24 | $150.1M | $59.2M | ||
| Q3 24 | $157.3K | $57.1M | ||
| Q2 24 | $159.8K | $53.0M | ||
| Q1 24 | $170.6K | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7M | $2.3M |
| Free Cash FlowOCF − Capex | $1.7M | $2.2M |
| FCF MarginFCF / Revenue | 7.6% | 12.0% |
| Capex IntensityCapex / Revenue | 0.1% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0K | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $2.3M | ||
| Q3 25 | $-4.8M | $-1.3M | ||
| Q2 25 | $2.2M | $1.8M | ||
| Q1 25 | $1.1M | $-3.5M | ||
| Q4 24 | $3.2M | $865.0K | ||
| Q3 24 | $6.5M | $4.3M | ||
| Q2 24 | $7.3M | $1.4M | ||
| Q1 24 | $7.4M | $-2.4M |
| Q4 25 | $1.7M | $2.2M | ||
| Q3 25 | $-4.9M | $-1.5M | ||
| Q2 25 | $2.1M | $1.7M | ||
| Q1 25 | $1.0M | $-3.5M | ||
| Q4 24 | $2.5M | $470.0K | ||
| Q3 24 | $6.5M | $4.1M | ||
| Q2 24 | $7.3M | $1.2M | ||
| Q1 24 | $6.9M | $-2.5M |
| Q4 25 | 7.6% | 12.0% | ||
| Q3 25 | -18.1% | -9.6% | ||
| Q2 25 | 9.1% | 10.5% | ||
| Q1 25 | 5.0% | -18.8% | ||
| Q4 24 | 10.2% | 1.9% | ||
| Q3 24 | 21.7% | 14.4% | ||
| Q2 24 | 28.5% | 4.5% | ||
| Q1 24 | 28.1% | -11.1% |
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 0.4% | 1.4% | ||
| Q2 25 | 0.0% | 1.0% | ||
| Q1 25 | 0.1% | 0.3% | ||
| Q4 24 | 3.0% | 1.6% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.0% | 1.1% | ||
| Q1 24 | 2.0% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
